Pedro Luis Sánchez Fernández-rekin lankidetzan egindako argitalpenak (10)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2021

  1. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

2020

  1. Durable left ventricular assist device therapy in non transplant centers in Spain: initial experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 338-340

  2. Transcaval access to the abdominal aorta: Indications of interest to surgeons and a comprehensive literature review

    Brazilian Journal of Cardiovascular Surgery, Vol. 35, Núm. 5, pp. 781-788

2018

  1. Left Ventricular Assist Device Therapy for Destination Therapy: Is Less Invasive Surgery a Safe Alternative?

    Revista Espanola de Cardiologia, Vol. 71, Núm. 1, pp. 13-17

  2. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2017

  1. Comprehensive Assessment of the Heartware HVAD Left Ventricular Assist Device With 4-Dimensional Cardiac Computed Tomography

    Revista Espanola de Cardiologia, Vol. 70, Núm. 11, pp. 1010-1011

2016

  1. Asistencia ventricular izquierda para terapia de destino: primera experiencia en septuagenarios

    Cirugia Cardiovascular, Vol. 23, pp. 49-54

2003

  1. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction

    European Heart Journal, Vol. 24, Núm. 22, pp. 2012-2020

1993

  1. Oat-cell carcinoma of primary location in the pericardium. A case report

    Tumori, Vol. 79, Núm. 2, pp. 144-146